Adipose tissue and atherosclerosis - Exploring the connection

被引:311
作者
Fantuzzi, Giamila
Mazzone, Theodore
机构
[1] Univ Illinois, Sect Endocrinol Diabet & Metab, Dept Human Nutr, Chicago, IL 60612 USA
[2] Univ Illinois, Dept Med, Chicago, IL 60612 USA
[3] Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA
关键词
obesity; atherosclerosis; adipocytokines; lipoprotein metabolism; visceral fat;
D O I
10.1161/ATVBAHA.106.131755
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The prevalence of obesity, especially among the young, is dramatically increasing in the United States. Obesity is associated with accelerated atherosclerosis and increased rates of cardiovascular death. There are many plausible mechanisms by which an increase in adipose tissue could adversely affect the vessel wall. These include the changes in blood pressure, glucose level, lipid/lipoprotein metabolism, and systemic inflammation. In addition, factors secreted by adipose tissue may directly influence vessel wall homeostasis by influencing the function of endothelial cells, arterial smooth muscle cells, and macrophages in the vessel wall. There is general agreement that central, as opposed to peripheral, adipose tissue confers the most cardio-metabolic risk. Although the basis of this differential risk has not been not established, the pattern of gene expression and secretory products in visceral fat would be predicted to be more atherogenic compared with that in subcutaneous peripheral fat. Numerous studies have shown the beneficial effects of weight loss on markers of cardiovascular risk but fewer have demonstrated improvement in direct measures of large vessel disease. The unfolding role of adipose tissue as an important metabolic and secretory organ provides new opportunities for developing more effective approaches for preventing obesity and its atherosclerotic complications.
引用
收藏
页码:996 / 1003
页数:8
相关论文
共 113 条
  • [1] Effect of adiponectin on carotid arterial stiffness in type 2 diabetic patients treated with pioglitazone and metformin
    Araki, Takahiro
    Emoto, Masanori
    Teramura, Megumi
    Yokoyama, Hisayo
    Mori, Katsuhito
    Hatsuda, Sawako
    Maeno, Takaaki
    Shinohara, Kayo
    Koyama, Hidenori
    Shoji, Tetsuo
    Inaba, Masaaki
    Nishizawa, Yoshiki
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2006, 55 (08): : 996 - 1001
  • [2] Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell
    Arita, Y
    Kihara, S
    Ouchi, N
    Maeda, K
    Kuriyama, H
    Okamoto, Y
    Kumada, M
    Hotta, K
    Nishida, M
    Takahashi, M
    Nakamura, T
    Shimomura, I
    Muraguchi, M
    Ohmoto, Y
    Funahashi, T
    Matsuzawa, Y
    [J]. CIRCULATION, 2002, 105 (24) : 2893 - 2898
  • [3] Comparison of serum high-molecular weight (HMS adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin
    Aso, Yoshimasa
    Yamamoto, Ruriko
    Wakabayashi, Sadao
    Uchida, Toshihiko
    Takayanagi, Kan
    Takebayashi, Kohzo
    Okuno, Takehiko
    Inoue, Teruo
    Node, Koichi
    Tobe, Takashi
    Inukai, Toshihiko
    Nakano, Yasuko
    [J]. DIABETES, 2006, 55 (07) : 1954 - 1960
  • [4] The effect of weight loss with or without exercise training on large artery compliance in healthy obese men
    Balkestein, EJ
    van Aggel-Leijssen, DP
    van Baak, MA
    Struijker-Boudier, HA
    Van Bortel, LM
    [J]. JOURNAL OF HYPERTENSION, 1999, 17 (12) : 1831 - 1835
  • [5] Surgical removal of visceral fat reverses hepatic insulin resistance
    Barzilai, N
    She, L
    Liu, BQ
    Vuguin, P
    Cohen, P
    Wang, JL
    Rossetti, L
    [J]. DIABETES, 1999, 48 (01) : 94 - 98
  • [6] Adipose tissue, inflammation, and cardiovascular disease
    Berg, AH
    Scherer, PE
    [J]. CIRCULATION RESEARCH, 2005, 96 (09) : 939 - 949
  • [7] Billington CJ, 2000, ARCH INTERN MED, V160, P898, DOI 10.1001/archinte.160.7.898
  • [8] Changes of adiponectin oligomer composition by moderate weight reduction
    Bobbert, T
    Rochlitz, H
    Wegewitz, U
    Akpulat, S
    Mai, K
    Weickert, MO
    Möhlig, M
    Pfeiffer, AFH
    Spranger, J
    [J]. DIABETES, 2005, 54 (09) : 2712 - 2719
  • [9] Recombinant leptin promotes atherosclerosis and thrombosis in apolipoprotein E-deficient mice
    Bodary, PF
    Gu, SF
    Shen, YC
    Hasty, AH
    Buckler, JM
    Eitzman, DT
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (08) : 119 - 122
  • [10] Leptin induces oxidative stress in human endothelial cells
    Bouloumié, A
    Marumo, T
    Lafontan, M
    Busse, R
    [J]. FASEB JOURNAL, 1999, 13 (10) : 1231 - 1238